|
Real-time
Euronext Paris
08:49:52 05/10/2026 BST
|
5-day change | 1st Jan Change | ||
| 0.7100 EUR | +1.43% |
|
-2.74% | -26.04% |
| 09-25 | Transgene provides update on its operations |  |
| 09-08 | Transgene Expands ProBioGen Partnership With Additional License | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| TRANSGENE | Bio Therapeutic Drugs | +1.43% | -2.74% | -26.04% | -36.04% | -70.29% | 216M |  | | |
- Stock Market
- Stocks
- TNG Stock
- Charts Transgene
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
